MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jtocrr.2026.101038

Медицинская библиотека · JTO clinical and research reports · 2026

Living With ALK Fusion-Positive NSCLC: A French Nationwide Survey of the Psychosocial Impact Among Patients, Caregivers, and Health Care Professionals.

Cadranel Jacques, Corre Romain, Roget Peggy, Wingler Michael, Alliaume Sandrine, Bausson Pascale, Capdevielle Leslie, Mendes Joana, Mogenet Alice, Mennecier Bertrand

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

The development of ALK inhibitors has transformed the management of ALK fusion-positive (ALK+) NSCLC from a high-mortality disease to a more manageable chronic condition.

METHODS

This quantitative, nationwide French survey collated information via online questionnaires from patients (n = 85), caregivers (n = 27), and health care professionals (HCPs; n = 50) on the impact of ALK+ NSCLC on daily lives and psychosocial issues.

RESULTS

Overall, 46 patients (54%) had received first-line and 39 patients (46%) second-line or later targeted therapy for a mean of 2.4 years. The most common disease-related challenges reported by patients and HCPs were psychological issues (56.5% and 78.0%), life-planning difficulties (50.6% and 64.0%), and limitations in physical activities of daily life (40.0% and 48.0%), respectively. HCPs consistently underestimated the impact of ALK+ NSCLC on patients' daily lives, especially regarding psychological difficulties, issues with relationships and intimacy, and financial struggles. ALK+ NSCLC had a major impact on caregivers' psychological problems, difficulties in realizing life plans, and professional difficulties. The most important patient-rated support and guidance needs were to establish a separate clinic dedicated to nonmedical problems, improve the systematic provision of wellness activities (e.g., yoga), make it easier to report adverse events to the medical team, provide psychological support, and enable exchanges with other patients (e.g., via discussion groups).

CONCLUSIONS

Our study highlights several measures that can be introduced to reduce disease burden and improve quality of life and, besides routine medical follow-up, markedly improve the overall patient journey through ALK+ NSCLC.

Для цитирования: Cadranel Jacques, Corre Romain, Roget Peggy, Wingler Michael, Alliaume Sandrine, Bausson Pascale, Capdevielle Leslie, Mendes Joana, Mogenet Alice, Mennecier Bertrand. Living With ALK Fusion-Positive NSCLC: A French Nationwide Survey of the Psychosocial Impact Among Patients, Caregivers, and Health Care Professionals.. JTO clinical and research reports. 2026. DOI: 10.1016/j.jtocrr.2026.101038.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.